Skip Nav Destination
Issues
Highlights
CCR Translations
CCR Drug Updates
Molecular Pathways
Perspective
Reviews
Human Cancer Biology
Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome
Yoshitsugu Mitani; Pulivarthi H. Rao; P. Andrew Futreal; Dianna B. Roberts; Philip J. Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S. Weber; Scott M. Lippman; Carlos Caulin; Adel K. El-Naggar
Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
Aditi Bhattacharya; Ritu Roy; Antoine M. Snijders; Gregory Hamilton; Jesse Paquette; Taku Tokuyasu; Henrik Bengtsson; Richard C. K. Jordan; Adam B. Olshen; Daniel Pinkel; Brian L. Schmidt; Donna G. Albertson
Cancer Therapy: Preclinical
Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4
Conrad R. Cruz; Ulrike Gerdemann; Ann M. Leen; Jessica A. Shafer; Stephanie Ku; Benjamin Tzou; Terzah M. Horton; Andrea Sheehan; Amanda Copeland; Anas Younes; Cliona M. Rooney; Helen E. Heslop; Catherine M. Bollard
A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
Xiangdong Liu; Qian Wang; Gengjie Yang; Cindy Marando; Holly K. Koblish; Leslie M. Hall; Jordan S. Fridman; Elham Behshad; Richard Wynn; Yu Li; Jason Boer; Sharon Diamond; Chunhong He; Meizhong Xu; Jincong Zhuo; Wenqing Yao; Robert C. Newton; Peggy A. Scherle
Imaging, Diagnosis, Prognosis
A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
Martin J. van den Bent; Lonneke A. Gravendeel; Thierry Gorlia; Johan M. Kros; Lariesa Lapre; Pieter Wesseling; Johannes L. Teepen; Ahmed Idbaih; Marc Sanson; Peter A.E. Sillevis Smitt; Pim J. French
Cancer Therapy: Clinical
Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors
Ferry A.L.M. Eskens; Maja J.A. de Jonge; Pankaj Bhargava; Toshiyuki Isoe; Monette M. Cotreau; Brooke Esteves; Kunihiko Hayashi; Herman Burger; Maarten Thomeer; Leni van Doorn; Jaap Verweij
A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
Mahsa Mohebtash; Kwong-Yok Tsang; Ravi A. Madan; Ngar-Yee Huen; Diane J. Poole; Caroline Jochems; Jacquin Jones; Theresa Ferrara; Christopher R. Heery; Philip M. Arlen; Seth M. Steinberg; Mary Pazdur; Myrna Rauckhorst; Elizabeth C. Jones; William L. Dahut; Jeffrey Schlom; James L. Gulley
GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy
Guru Sonpavde; Timothy C. Thompson; Rajul K. Jain; Gustavo E. Ayala; Shinji Kurosaka; Kohei Edamura; Ken-ichi Tabata; Chengzhen Ren; Alexei A. Goltsov; Martha P. Mims; Teresa G. Hayes; Michael M. Ittmann; Thomas M. Wheeler; Adrian Gee; Brian J. Miles; Dov Kadmon
Predictive Biomarkers and Personalized Medicine
Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437
Monica M. Reinholz; Kathleen A. Kitzmann; Kathleen Tenner; David Hillman; Amylou C. Dueck; Timothy J. Hobday; Donald W. Northfelt; Alvaro Moreno-Aspitia; Vivek Roy; Betsy LaPlant; Jake B. Allred; Philip J. Stella; Wilma L. Lingle; Edith A. Perez
Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer
Joseph A. Sparano; Lori J. Goldstein; Barrett H. Childs; Steven Shak; Diana Brassard; Sunil Badve; Frederick L. Baehner; Roberto Bugarini; Steve Rowley; Edith A. Perez; Lawrence N. Shulman; Silvana Martino; Nancy E. Davidson; Paraic A. Kenny; George W. Sledge, Jr; Robert Gray
Advertisement
